Stonebridge Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-53
| Closed | -$3.79K | – | 930 |
|
|
2023
Q2 | $3.79K | Sell |
53
-575
| -92% | -$41.2K | ﹤0.01% | 748 |
|
|
2023
Q1 | $43.6K | Buy |
628
+53
| +9% | +$3.68K | 0.01% | 385 |
|
|
2022
Q4 | $39K | Buy |
575
+242
| +73% | +$16.4K | ﹤0.01% | 388 |
|
|
2022
Q3 | $18K | Buy |
333
+27
| +9% | +$1.46K | ﹤0.01% | 486 |
|
|
2022
Q2 | $20K | Sell |
306
-135
| -31% | -$8.82K | ﹤0.01% | 489 |
|
|
2022
Q1 | $29K | Hold |
441
| – | – | ﹤0.01% | 472 |
|
|
2021
Q4 | $26K | Sell |
441
-41
| -9% | -$2.42K | ﹤0.01% | 466 |
|
|
2021
Q3 | $29K | Sell |
482
-287
| -37% | -$17.3K | ﹤0.01% | 423 |
|
|
2021
Q2 | $42K | Buy |
769
+441
| +134% | +$24.1K | ﹤0.01% | 497 |
|
|
2021
Q1 | $16K | Buy |
+328
| New | +$16K | ﹤0.01% | 540 |
|
|
2020
Q3 | – | Sell |
-361
| Closed | -$19K | – | 224 |
|
|
2020
Q2 | $19K | Hold |
361
| – | – | ﹤0.01% | 404 |
|
|
2020
Q1 | $16K | Sell |
361
-484
| -57% | -$21.5K | ﹤0.01% | 413 |
|
|
2019
Q4 | $42K | Buy |
845
+454
| +116% | +$22.6K | 0.01% | 341 |
|
|
2019
Q3 | $17K | Hold |
391
| – | – | ﹤0.01% | 472 |
|
|
2019
Q2 | $16K | Buy |
+391
| New | +$16K | ﹤0.01% | 495 |
|